Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypothalamic dysfunction in Parkinson's disease patients

K Otake1, Y Oiso, T Mitsuma

  • 1First Department of Internal Medicine, Nagoya University School of Medicine, Japan.

Acta Medica Hungarica
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polymerization of recombinant Hb S-Kempsey (deoxy-R state) and Hb S-Kansas (oxy-T state).

The Journal of biological chemistry·1995
Same author

Studies on urea synthesis in the liver of rats treated chronically with ethanol using perfused livers, isolated hepatocytes, and mitochondria.

Biochemical pharmacology·1995
Same author

Involvement of epidermal growth factor in inducing adiposity of age female mice.

The Journal of endocrinology·1995
Same author

Adhalin gene mutations in patients with autosomal recessive childhood onset muscular dystrophy with adhalin deficiency.

The Journal of clinical investigation·1995
Same author

Acute myeloblastic leukemia (M2) with translocation (7;11) followed by marked eosinophilia and additional abnormalities of chromosome 5.

Cancer genetics and cytogenetics·1995
Same author

Mitochondrial encephalomyopathy with A to G transition of mitochondrial transfer RNA(Leu(UUR)) 3,243 presenting hypertrophic cardiomyopathy.

Internal medicine (Tokyo, Japan)·1995
Same journal

Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.

Acta medica Hungarica·1994
Same journal

Cytokines in the treatment of malignancies.

Acta medica Hungarica·1994
Same journal

Osteoporosis--a modifying factor of surgical treatment.

Acta medica Hungarica·1994
Same journal

New aspects in the treatment of bone sarcomas.

Acta medica Hungarica·1994
Same journal

Bone tumours in childhood.

Acta medica Hungarica·1994
Same journal

Lymphadenectomy in gastrointestinal cancer surgery.

Acta medica Hungarica·1994
See all related articles

Parkinson's disease (PD) patients exhibit abnormal pituitary hormone secretion, indicated by elevated prolactin (PRL) levels. This suggests hypothalamic dysfunction in individuals with PD, impacting hormone regulation.

Area of Science:

  • Neuroendocrinology
  • Neurology
  • Endocrinology

Background:

  • Idiopathic Parkinson's disease (PD) is a neurodegenerative disorder primarily affecting motor function.
  • Previous research suggests potential neuroendocrine alterations in PD patients.
  • The role of hypothalamic-pituitary axis dysfunction in PD pathophysiology requires further investigation.

Purpose of the Study:

  • To investigate pituitary hormone secretion patterns in patients with idiopathic Parkinson's disease (PD).
  • To assess the impact of TRH (thyrotropin-releasing hormone) and levodopa stimulation on prolactin (PRL) levels in PD patients.
  • To determine if hypothalamic dysfunction contributes to endocrine abnormalities observed in PD.

Main Methods:

  • Comparative study involving three groups: treatment-naive PD patients (Group A), treated PD patients (Group B), and healthy controls.

Related Experiment Videos

  • Administration of thyrotropin-releasing hormone (TRH) tests to assess TSH and PRL responses.
  • Administration of levodopa tests to evaluate PRL secretion dynamics.
  • Measurement of basal, peak, and nadir plasma PRL and TSH levels.

    • Main Results:

    • Group A (untreated PD) showed significantly higher basal PRL levels and elevated peak PRL during TRH tests compared to controls.
    • Nadir PRL levels during levodopa tests were significantly increased in both untreated and treated PD patients.
    • Group B (treated PD) exhibited higher basal PRL and TSH levels, with elevated peak PRL during TRH tests and nadir PRL during levodopa tests compared to controls.

    Conclusions:

    • Parkinson's disease patients display significant disturbances in pituitary hormone secretion, particularly prolactin.
    • Elevated PRL levels and altered responses to TRH and levodopa suggest underlying hypothalamic dysfunction in PD.
    • These findings highlight the neuroendocrine impact of PD and support the hypothesis of hypothalamic involvement in the disease process.